Notable Analyst Upgrades and Downgrades for Week of January 9 2023 (Part 1)

 


 

Upgrades:



Enterprise Products Partners (NYSE:EPD) was upgraded by investment analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating in a note issued to investors on Monday, The Fly reports. The firm presently has a $27.00 price target on the oil and gas producer's stock. Wolfe Research's price objective would indicate a potential upside of 8.00% from the company's previous close.

Other equities analysts have also issued research reports about the company. Tudor, Pickering, Holt & Co. lowered Enterprise Products Partners from a "buy" rating to a "hold" rating and set a $29.00 target price for the company. in a research note on Tuesday, October 18th. Tudor Pickering lowered Enterprise Products Partners from a "buy" rating to a "hold" rating and set a $29.00 target price for the company. in a research note on Tuesday, October 18th. Citigroup initiated coverage on Enterprise Products Partners in a research note on Thursday, December 8th. They issued a "buy" rating and a $31.00 target price for the company. Finally, StockNews.com began coverage on Enterprise Products Partners in a research note on Wednesday, October 12th. They set a "buy" rating for the company. Three research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Enterprise Products Partners presently has an average rating of "Moderate Buy" and an average price target of $30.50. Read more ...



Stryker (NYSE:SYK) was upgraded by equities researchers at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating in a research report issued on Monday, The Fly reports.

Several other research firms have also commented on SYK. Truist Financial boosted their price target on Stryker from $230.00 to $252.00 and gave the stock a “hold” rating in a research report on Tuesday, December 20th. StockNews.com raised Stryker from a “hold” rating to a “buy” rating in a research report on Friday, November 4th. Barclays upped their target price on Stryker from $257.00 to $265.00 in a research report on Wednesday, January 4th. Morgan Stanley boosted their price target on Stryker from $220.00 to $260.00 and gave the company an “equal weight” rating in a research note on Friday. Finally, Canaccord Genuity Group downgraded Stryker from a “buy” rating to a “hold” rating and dropped their price target for the company from $225.00 to $220.00 in a research note on Tuesday, November 1st. Six analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, Stryker has a consensus rating of “Moderate Buy” and an average price target of $258.37. Read more …



Ally Financial (NYSE:ALLY) was upgraded by investment analysts at Piper Sandler from an “underweight” rating to a “neutral” rating in a note issued to investors on Monday, The Fly reports.

A number of other equities research analysts have also issued reports on ALLY. S&P Equity Research set a $29.50 target price on Ally Financial in a research report on Monday, November 14th. Compass Point lowered Ally Financial from a “buy” rating to a “neutral” rating in a research report on Wednesday, October 26th. Credit Suisse Group dropped their target price on Ally Financial from $44.00 to $38.00 and set an “outperform” rating on the stock in a research report on Thursday, October 20th. StockNews.com lowered Ally Financial from a “hold” rating to a “sell” rating in a research report on Monday, December 5th. Finally, Bank of America lowered Ally Financial from a “buy” rating to an “underperform” rating and dropped their target price for the company from $35.00 to $26.00 in a research report on Thursday. Four analysts have rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $35.82. Read more …




Mizuho upgraded shares of Exxon Mobil (NYSE:XOM) from a neutral rating to a buy rating in a research report sent to investors on Tuesday, MarketBeat Ratings reports. Mizuho currently has $140.00 target price on the oil and gas company’s stock, up from their prior target price of $90.00.

XOM has been the subject of a number of other reports. Truist Financial lifted their price objective on Exxon Mobil from $111.00 to $114.00 in a report on Monday, October 31st. Morgan Stanley lifted their price objective on Exxon Mobil from $113.00 to $114.00 and gave the company an overweight rating in a report on Wednesday, October 19th. Barclays lifted their price objective on Exxon Mobil from $111.00 to $129.00 and gave the company an overweight rating in a report on Tuesday, January 3rd. Exane BNP Paribas upgraded Exxon Mobil from an underperform rating to a neutral rating and set a $115.00 target price for the company in a research note on Tuesday, November 1st. Finally, BNP Paribas upgraded Exxon Mobil from an underperform rating to a neutral rating and set a $115.00 target price for the company in a research note on Tuesday, November 1st. Eight investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of Moderate Buy and an average target price of $113.41. Read more …



American Tower (NYSE:AMT) was upgraded by equities researchers at The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research report issued on Tuesday, Marketbeat reports. The brokerage currently has a $245.00 price objective on the real estate investment trust’s stock, up from their previous price objective of $215.00. The Goldman Sachs Group’s target price would indicate a potential upside of 7.40% from the stock’s previous close.

Several other equities research analysts also recently weighed in on AMT. Wells Fargo & Company raised their price target on American Tower from $225.00 to $245.00 in a report on Wednesday, December 14th. Barclays raised their price target on American Tower from $232.00 to $247.00 and gave the stock an “overweight” rating in a report on Monday, November 14th. Deutsche Bank Aktiengesellschaft lowered their price target on American Tower from $323.00 to $240.00 in a report on Friday, December 16th. UBS Group lowered their price target on American Tower from $278.00 to $270.00 in a report on Tuesday, December 13th. Finally, Cowen lowered their price target on American Tower to $279.00 in a report on Tuesday, November 1st. Three research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $263.69. Read more …



KGI Securities upgraded shares of NIKE (NYSE:NKE) from a neutral rating to an outperform rating in a research report sent to investors on Tuesday morning, The Fly reports.

Other analysts also recently issued reports about the company. Telsey Advisory Group raised their price objective on NIKE from $130.00 to $133.00 and gave the stock an outperform rating in a research report on Wednesday, December 21st. JPMorgan Chase & Co. set a $128.00 price objective on NIKE in a research report on Monday, January 2nd. UBS Group raised their price objective on NIKE from $141.00 to $146.00 and gave the stock a buy rating in a research report on Wednesday, December 21st. HSBC lowered their target price on NIKE to $100.00 in a report on Thursday, October 20th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on NIKE from $126.00 to $133.00 and gave the company a buy rating in a report on Wednesday, December 21st. Twelve equities research analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average price target of $126.89. Read more …




Downgrades:



The Goldman Sachs Group downgraded shares of MetLife (NYSE:MET) from a buy rating to a neutral rating in a report released on Monday morning, Marketbeat Ratings reports. The brokerage currently has $78.00 price target on the financial services provider’s stock, down from their previous price target of $80.00.

A number of other research firms have also weighed in on MET. Wells Fargo & Company lowered their target price on shares of MetLife from $75.00 to $74.00 and set an overweight rating on the stock in a report on Wednesday, October 12th. Morgan Stanley upped their target price on shares of MetLife from $85.00 to $87.00 and gave the stock an overweight rating in a report on Thursday, November 17th. Raymond James assumed coverage on shares of MetLife in a research note on Wednesday, September 21st. They issued a market perform rating for the company. StockNews.com assumed coverage on shares of MetLife in a research note on Wednesday, October 12th. They issued a hold rating for the company. Finally, Jefferies Financial Group lowered shares of MetLife from a buy rating to a hold rating and decreased their price objective for the company from $86.00 to $82.00 in a research note on Friday, December 9th. Four research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of Moderate Buy and an average target price of $79.08. Read more …



Prudential Financial (NYSE:PRU) was downgraded by analysts at The Goldman Sachs Group from a "neutral" rating to a "sell" rating in a research report issued to clients and investors on Monday, The Fly reports.

A number of other brokerages have also issued reports on PRU. Wells Fargo & Company lowered Prudential Financial from an "equal weight" rating to an "underweight" rating and set a $101.00 price target for the company. in a research note on Friday, December 16th. Citigroup raised their price target on Prudential Financial from $98.00 to $105.00 in a research note on Wednesday, November 16th. Morgan Stanley raised their price target on Prudential Financial from $111.00 to $112.00 and gave the stock an "equal weight" rating in a research note on Thursday, November 17th. Raymond James lowered Prudential Financial from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, November 23rd. Finally, Credit Suisse Group decreased their target price on Prudential Financial to $102.00 in a research report on Thursday, September 29th. Four equities research analysts have rated the stock with a sell rating and ten have issued a hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $104.77. Read more …



Medtronic (NYSE:MDT) was downgraded by stock analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating in a report issued on Monday, The Fly reports.

Several other research analysts have also recently issued reports on the company. Cowen reduced their price objective on Medtronic from $117.00 to $90.00 in a research note on Wednesday, November 23rd. Stifel Nicolaus dropped their target price on Medtronic from $105.00 to $90.00 in a report on Wednesday, November 23rd. Oppenheimer lowered Medtronic from an "outperform" rating to a "market perform" rating and dropped their price objective for the company from $106.00 to $85.00 in a report on Wednesday, November 23rd. Barclays dropped their price objective on Medtronic from $90.00 to $85.00 and set an "equal weight" rating on the stock in a report on Friday, November 25th. Finally, Piper Sandler dropped their price objective on Medtronic from $90.00 to $80.00 in a report on Tuesday, November 22nd. One investment analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Medtronic currently has a consensus rating of "Hold" and an average target price of $97.26. Read more …




Consolidated Edison (NYSE:ED) was downgraded by equities researchers at Mizuho from a "buy" rating to a "neutral" rating in a research note issued to investors on Monday, The Fly reports.

ED has been the topic of several other reports. StockNews.com began coverage on Consolidated Edison in a report on Wednesday, October 12th. They set a "hold" rating on the stock. Credit Suisse Group decreased their price objective on Consolidated Edison from $94.00 to $82.00 in a report on Monday, October 10th. Guggenheim decreased their price objective on Consolidated Edison from $94.00 to $82.00 in a report on Monday, October 24th. Morgan Stanley increased their price target on Consolidated Edison from $73.00 to $78.00 and gave the company an "underweight" rating in a report on Thursday, December 15th. Finally, Royal Bank of Canada increased their price target on Consolidated Edison from $89.00 to $90.00 and gave the company a "sector perform" rating in a report on Monday, October 3rd. Four analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $86.00. Read more …



Raymond James lowered shares of Realty Income (NYSE:O) from an outperform rating to a market perform rating in a research report released on Monday morning, The Fly reports.

A number of other research firms have also recently weighed in on O. Mizuho increased their price objective on Realty Income from $61.00 to $64.00 and gave the stock a neutral rating in a research report on Thursday, December 8th. Morgan Stanley reduced their price target on Realty Income from $76.00 to $74.00 and set an overweight rating for the company in a report on Tuesday, October 25th. Finally, StockNews.com cut Realty Income from a hold rating to a sell rating in a report on Thursday, January 5th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of Hold and a consensus price target of $72.00. Read more …



Mizuho lowered shares of Chevron (NYSE:CVX) from a buy rating to a neutral rating in a research note released on Tuesday, Marketbeat reports. The brokerage currently has $200.00 price objective on the oil and gas company’s stock, up from their prior price objective of $185.00.

CVX has been the topic of several other reports. Bank of America downgraded shares of Chevron from a buy rating to a neutral rating and increased their target price for the stock from $190.00 to $191.00 in a research report on Friday, January 6th. Morgan Stanley increased their target price on shares of Chevron from $193.00 to $196.00 and gave the stock an equal weight rating in a research report on Wednesday, October 19th. Jefferies Financial Group initiated coverage on shares of Chevron in a report on Wednesday, October 19th. They set a hold rating for the company. Piper Sandler decreased their price target on shares of Chevron from $206.00 to $199.00 and set an overweight rating for the company in a report on Monday, December 19th. Finally, StockNews.com initiated coverage on shares of Chevron in a report on Wednesday, October 12th. They set a hold rating for the company. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of Hold and an average target price of $186.67. Read more …




C.H. Robinson Worldwide (NASDAQ:CHRW) was downgraded by research analysts at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a note issued to investors on Tuesday, The Fly reports.

Other equities analysts have also recently issued reports about the company. Citigroup lowered their price objective on C.H. Robinson Worldwide from $107.00 to $94.00 and set a “neutral” rating on the stock in a research report on Thursday, November 3rd. BNP Paribas assumed coverage on C.H. Robinson Worldwide in a report on Wednesday, November 30th. They set an “outperform” rating and a $128.00 price target on the stock. Barclays lowered their price target on C.H. Robinson Worldwide from $100.00 to $96.00 and set an “equal weight” rating on the stock in a report on Thursday, October 13th. BMO Capital Markets lowered their price target on C.H. Robinson Worldwide from $95.00 to $90.00 and set a “market perform” rating on the stock in a report on Monday. Finally, KeyCorp lowered their price target on C.H. Robinson Worldwide from $135.00 to $120.00 and set an “overweight” rating on the stock in a report on Thursday, November 3rd. Five equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, C.H. Robinson Worldwide currently has an average rating of “Hold” and a consensus price target of $104.08. Read more ...



Archive of Upgrades and Downgrades


Comments